Litcius/Paper detail

MC1675, a Phase III Evaluation of De-Escalated Adjuvant Radiation Therapy (DART) vs. Standard Adjuvant Treatment for Human Papillomavirus Associated Oropharyngeal Squamous Cell Carcinoma

De-Liang Ma, Katharine A. Price, Eric J. Moore, Samir H. Patel, M.L. Hinni, Briant Fruth, Nathan R. Foster, K. Van Abel, Linda X. Yin, M.A. Neben-Wittich, L.A. McGee, J.C. Rwigema, David M. Routman, Scott C. Lester, Daniel L. Price, Jeffrey R. Janus, Jan L. Kasperbauer, Thomas H. Nagel, Ashish V. Chintakuntlawar, P. Savvides, J.J. Garcia, Robert L. Foote

2021International Journal of Radiation Oncology*Biology*Physics54 citationsDOI

Topics & Concepts

MedicineAdjuvantHuman papillomavirusOncologyAdjuvant radiotherapyBasal cellInternal medicineRadiation therapyAdjuvant therapyCancerHead and Neck Cancer StudiesLung Cancer Diagnosis and TreatmentColorectal and Anal Carcinomas
MC1675, a Phase III Evaluation of De-Escalated Adjuvant Radiation Therapy (DART) vs. Standard Adjuvant Treatment for Human Papillomavirus Associated Oropharyngeal Squamous Cell Carcinoma | Litcius